Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2000
11/07/2000CA2061689C Process for the preparation of alpha-acetolactic acid
11/07/2000CA2024767C Interferon-gamma receptor fragment and its production
11/06/2000CA2270417A1 Transgenic reduction of the sinapine content in brassica napus seeds
11/03/2000CA2270360A1 A target for therapeutic reagents to stop the production of all forms of the abeta amyloid peptide (a.beta.) from the amyloid precursor protein (app) in humans
11/02/2000WO2000065421A2 Receptor selectivity mapping
11/02/2000WO2000065357A1 Method of diagnosing transmissible spongiform encephalopathies
11/02/2000WO2000065340A1 Protein-protein interactions
11/02/2000WO2000065137A1 Microelectromechanical devices useful for manipulating cells or embryos, kits thereof, methods of making same, and methods of use thereof
11/02/2000WO2000065099A1 Monolayer and electrode for detecting a label-bearing target and method of use thereof
11/02/2000WO2000065097A1 Biochip and method for making it
11/02/2000WO2000065080A1 Antibiotic-based gene regulation system
11/02/2000WO2000065078A1 A herpes simplex virus type 1 (hsv-1)-derived vector for selectively inhibiting malignant cells and methods for its use to treat cancers and to express desired traits in malignant and non-malignant mammalian cells
11/02/2000WO2000065077A1 Triple hybrid amplicon vector systems to generate retroviral packaging lines
11/02/2000WO2000065076A2 Synthetic gene for expressing active retroviral protein in eukaryotes
11/02/2000WO2000065075A1 Use of coxsackie viruses for improving cell transfection
11/02/2000WO2000065074A1 Promoter-transactivator system for inducible high-level mammalian gene expression with the option of cell growth control
11/02/2000WO2000065073A2 Genetic sequence which codes for the flavon synthase ii enzyme and use of the same
11/02/2000WO2000065072A1 Novel mannose isomerase and dna encoding the enzyme
11/02/2000WO2000065071A1 Nucleic acid molecule, containing a nucleic acid which codes for a polypeptide with chorismate mutase activity
11/02/2000WO2000065070A2 Cell culture process for glycoproteins
11/02/2000WO2000065069A1 Dsp-5 dual-specificity map kinase phosphatase
11/02/2000WO2000065068A1 Dsp-10 dual-specificity map kinsase phosphatase
11/02/2000WO2000065067A2 Prostate-specific polynucleotides, polypeptides and their methods of use
11/02/2000WO2000065066A1 Gluconobacter suboxydans sorbitol dehydrogenase, genes and methods of use thereof
11/02/2000WO2000065065A1 METHOD FOR OBTAINING RECOMBINANT HBsAg
11/02/2000WO2000065064A1 Peptides and assays for the diagnosis of lyme disease and compositions useful for the prevention thereof
11/02/2000WO2000065063A2 Nucleic acid vaccines against rickettsial diseases and methods of use
11/02/2000WO2000065062A2 Genome sequence and polypeptides of pyrococcus abissy, fragment and uses thereof
11/02/2000WO2000065061A2 Nucleic acid sequences from candida yeasts which code cytochrome b5 polypeptides
11/02/2000WO2000065060A2 Dna sequence and recombinant production of a graminae allergen
11/02/2000WO2000065059A1 Splicing factor
11/02/2000WO2000065058A1 Method for down-regulating il5 activity
11/02/2000WO2000065057A1 Inhibition of viral infection using monovalent antigen-binding proteins
11/02/2000WO2000065056A2 NUCLEIC ACIDS ENCODING A MutT DOMAIN-CONTAINING POLYPEPTIDE
11/02/2000WO2000065055A2 Human transporter proteins
11/02/2000WO2000065054A2 Human membrane-associated proteins
11/02/2000WO2000065053A2 Compositions and methods for therapy and diagnosis of head/neck and lung squamous cell carcinoma
11/02/2000WO2000065052A1 Bridge-1, a transcription factor
11/02/2000WO2000065051A1 Pollinosis-associated gene 627
11/02/2000WO2000065050A1 Pollinosis-associated gene 795
11/02/2000WO2000065049A1 Pollinosis-associated gene 513
11/02/2000WO2000065048A1 Pollinosis-associated gene 581
11/02/2000WO2000065047A1 Tumor suppressor genes
11/02/2000WO2000065046A1 Pollinosis-associated gene 373
11/02/2000WO2000065045A1 Pollinosis-associated gene 419
11/02/2000WO2000065044A1 Apoptosis-associated proteins
11/02/2000WO2000065043A1 Use of a recombinant defective adenovirus comprising a nucleic acid encoding an angiogenic factor for treating pulmonary hypertension
11/02/2000WO2000065042A1 P element derived vector and methods for its use
11/02/2000WO2000065041A1 Process for nucleic acid purification using silicon carbide
11/02/2000WO2000065040A2 Cell cycle genes from plants and methods of use
11/02/2000WO2000065039A2 Identification of dna control elements responsive to specific stimuli
11/02/2000WO2000065038A2 Methods, compositions, and cells for encapsidating recombinant vectors in aav particles
11/02/2000WO2000065037A2 Maize npr1 polynucleotides and methods of use
11/02/2000WO2000065036A2 Overexpression of a dna sequence coding for a 1-desoxy-d-xylulose-5-phosphate reductoisomerase in plants
11/02/2000WO2000065035A1 Telophase enucleated oocytes for nuclear transfer
11/02/2000WO2000065034A2 Pseudotyped retroviral vector for gene therapy of cancer
11/02/2000WO2000065033A1 Method and kit for indicating the level of bad breath
11/02/2000WO2000065032A1 Porcine reproductive and respiratory syndrome vaccine, based on isolate ja-142
11/02/2000WO2000065027A2 Human gil-19/ae289 proteins and polynucleotides encoding same
11/02/2000WO2000065025A2 Dna molecules encoding human endothelin converting enzyme 3
11/02/2000WO2000064946A2 Compositions and methods for cancer treatment by selectively inhibiting vegf
11/02/2000WO2000064944A1 Treatment of fibrosis by antagonism of il-13 and il-13 receptor chains
11/02/2000WO2000064943A1 Acrp30r1m, a homolog of acrp30
11/02/2000WO2000064942A1 Axor-27, a g-protein coupled receptor
11/02/2000WO2000064941A2 G-protein coupled receptor and method of using same
11/02/2000WO2000064939A2 Peptides derived from vasostatin i and the use thereof as anti-fungal agents
11/02/2000WO2000064935A1 A novel serotonin-gated anion channel
11/02/2000WO2000064933A1 Transcriptional activation inhibitory protein
11/02/2000WO2000064932A1 Neuronal exocytosis inhibiting peptides and cosmetic and pharmaceutical compositions containing said peptides
11/02/2000WO2000064931A1 A ligand of the protein 'beacon'
11/02/2000WO2000064930A2 Tribonectins
11/02/2000WO2000064929A1 Membrane disruptive peptides covalently oligomerized
11/02/2000WO2000064858A1 Bipolar lipids and their use for the delivery of bioactive substances
11/02/2000WO2000064488A2 Somatic transgene immunization and related methods
11/02/2000WO2000064482A1 Nerve cell growth modulators (amphibodies)
11/02/2000WO2000064469A2 Use of glucose-6-phospate isomerase and antibodies thereto for the diagnosis and therapy of arthritis, and test of anti-arthritic compounds
11/02/2000WO2000064465A1 Death domain containing receptors
11/02/2000WO2000064400A2 Methods for treating congestive heart failure
11/02/2000WO2000064262A1 Antisense human fucosyltransferase sequences and methods of use thereof
11/02/2000WO2000064247A1 Transgenic animals expressing salivary proteins
11/02/2000WO2000046379A8 Campylobacter glycosyltransferases for biosynthesis of gangliosides and ganglioside mimics
11/02/2000WO2000044889A3 Mammal with inducible ductal carcinoma in situ
11/02/2000WO2000043514A3 Human acid sensing ion channel and uses thereof
11/02/2000WO2000043509A3 Polynucleotides and their applications in diagnostics
11/02/2000WO2000043493A8 Metalloproteinase adam 22
11/02/2000WO2000042216A3 Genetic predisposition to abnormal calcification conditions
11/02/2000WO2000041516A3 Reagents and methods useful for detecting diseases of the breast
11/02/2000WO2000040741A3 Lentivirus vector system
11/02/2000WO2000040739B1 RIBONUCLEOTIDE REDUCTASE LARGE SUBUNIT (R1) cDNA AND USES THEREOF
11/02/2000WO2000040723A3 Methods and products for delivering nucleic acids
11/02/2000WO2000040714A3 Therapeutic phosphodiesterase inhibitors
11/02/2000WO2000040699A3 Astrocytes, their preparation and uses thereof
11/02/2000WO2000040271A3 P450 / acetaminophen gdept for cancer treatment
11/02/2000WO2000039299A3 Streptococcus antigens
11/02/2000WO2000039279A3 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
11/02/2000WO2000039136A3 Human brainiac-5
11/02/2000WO2000037642A9 Method of enhancing the biological activity of ligands
11/02/2000WO2000037640A9 Compositions and methods for the treatment of tumor
11/02/2000WO2000037504A9 Human monoclonal antibodies to ctla-4
11/02/2000WO2000037093A8 Bone resorption inhibitors
1 ... 3161 3162 3163 3164 3165 3166 3167 3168 3169 3170 3171 3172 3173 3174 3175 3176 3177 3178 3179 3180 3181 ... 4023